|
1
|
Levitus M, Joenje H and de Winter JP: The
Fanconi anemia pathway of genomic maintenance. Cell Oncol. 28:3–29.
2006.PubMed/NCBI
|
|
2
|
Kutler DI, Singh B, Satagopan J, et al: A
20-year perspective on the International Fanconi Anemia Registry
(IFAR). Blood. 101:1249–1256. 2003.PubMed/NCBI
|
|
3
|
Scheckenbach K, Wagenmann M, Freund M,
Schipper J and Hanenberg H: Squamous cell carcinomas of the head
and neck in Fanconi anemia: risk, prevention, therapy, and the need
for guidelines. Klin Padiatr. 224:132–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kutler DI, Auerbach AD, Satagopan J, et
al: High incidence of head and neck squamous cell carcinoma in
patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg.
129:106–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Masserot C, Peffault de Latour R, Rocha V,
et al: Head and neck squamous cell carcinoma in 13 patients with
Fanconi anemia after hematopoietic stem cell transplantation.
Cancer. 113:3315–3322. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosenberg PS, Socié G, Alter BP and
Gluckman E: Risk of head and neck squamous cell cancer and death in
patients with Fanconi anemia who did and did not receive
transplants. Blood. 105:67–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Birkeland AC, Auerbach AD, Sanborn E, et
al: Postoperative clinical radiosensitivity in patients with
fanconi anemia and head and neck squamous cell carcinoma. Arch
Otolaryngol Head Neck Surg. 137:930–934. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kutler DI, Wreesmann VB, Goberdhan A, et
al: Human papillomavirus DNA and p53 polymorphisms in squamous cell
carcinomas from Fanconi anemia patients. J Natl Cancer Inst.
95:1718–1721. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alter BP, Giri N, Savage SA, Quint WG, de
Koning MN and Schiffman M: Squamous cell carcinomas in patients
with Fanconi anemia and dyskeratosis congenita: a search for human
papillomavirus. Int J Cancer. 133:1513–1515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Zeeburg HJ, Snijders PJ, Pals G, et
al: Generation and molecular characterization of head and neck
squamous cell lines of fanconi anemia patients. Cancer Res.
65:1271–1276. 2005.PubMed/NCBI
|
|
11
|
Schlacher K, Wu H and Jasin M: A distinct
replication fork protection pathway connects Fanconi anemia tumor
suppressors to RAD51-BRCA1/2. Cancer Cell. 22:106–116. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gammon L, Biddle A, Fazil B, Harper L and
Mackenzie IC: Stem cell characteristics of cell sub-populations in
cell lines derived from head and neck cancers of Fanconi anemia
patients. J Oral Pathol Med. 40:143–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alison MR, Islam S and Wright NA: Stem
cells in cancer: instigators and propagators? J Cell Sci.
123:2357–2368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beck B and Blanpain C: Unravelling cancer
stem cell potential. Nat Rev Cancer. 13:727–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frank NY, Schatton T and Frank MH: The
therapeutic promise of the cancer stem cell concept. J Clin Invest.
120:41–50. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sampieri K and Fodde R: Cancer stem cells
and metastasis. Semin Cancer Biol. 22:187–193. 2012. View Article : Google Scholar
|
|
18
|
Noto Z, Yoshida T, Okabe M, et al: CD44
and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess
cancer stem-like cell characteristics. Oral Oncol. 49:787–795.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clay MR, Tabor M, Owen JH, et al:
Single-marker identification of head and neck squamous cell
carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck.
32:1195–1201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marcato P, Dean CA, Giacomantonio CA and
Lee PW: Aldehyde dehydrogenase: its role as a cancer stem cell
marker comes down to the specific isoform. Cell Cycle.
10:1378–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng S, Yang X, Lassus H, et al: Distinct
expression levels and patterns of stem cell marker, aldehyde
dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS
One. 5:e102772010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim MP, Fleming JB, Wang H, et al: ALDH
activity selectively defines an enhanced tumor-initiating cell
population relative to CD133 expression in human pancreatic
adenocarcinoma. PLoS One. 6:e206362011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Landen CN Jr, Goodman B, Katre AA, et al:
Targeting aldehyde dehydrogenase cancer stem cells in ovarian
cancer. Mol Cancer Ther. 9:3186–3199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brenner JC, Graham MP, Kumar B, et al:
Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell
lines. Head Neck. 32:417–426. 2010.PubMed/NCBI
|
|
26
|
Loh YH, Wu Q, Chew JL, et al: The Oct4 and
Nanog transcription network regulates pluripotency in mouse
embryonic stem cells. Nat Genet. 38:431–440. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao W, Ji X, Zhang F, Li L and Ma L:
Embryonic stem cell markers. Molecules. 17:6196–6236. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clevers H: The cancer stem cell: premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang S, Balch C, Chan MW, et al:
Identification and characterization of ovarian cancer-initiating
cells from primary human tumors. Cancer Res. 68:4311–4320. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Charafe-Jauffret E, Ginestier C, Iovino F,
et al: Aldehyde dehydrogenase 1-positive cancer stem cells mediate
metastasis and poor clinical outcome in inflammatory breast cancer.
Clin Cancer Res. 16:45–55. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang F, Qiu Q, Khanna A, et al: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li T, Su Y, Mei Y, et al: ALDH1A1 is a
marker for malignant prostate stem cells and predictor of prostate
cancer patients’ outcome. Lab Invest. 90:234–244. 2010.PubMed/NCBI
|
|
34
|
Ha PK and Califano JA: The molecular
biology of mucosal field cancerization of the head and neck. Crit
Rev Oral Biol Med. 14:363–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ha PK, Chang SS, Glazer CA, Califano JA
and Sidransky D: Molecular techniques and genetic alterations in
head and neck cancer. Oral Oncol. 45:335–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Blanpain C, Mohrin M, Sotiropoulou PA and
Passegué E: DNA-damage response in tissue-specific and cancer stem
cells. Cell Stem Cell. 8:16–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rangwala F, Omenetti A and Diehl AM:
Cancer stem cells: repair gone awry? J Oncol. 2011:4653432011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Taniguchi T and D’Andrea AD: Molecular
pathogenesis of Fanconi anemia: recent progress. Blood.
107:4223–4233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Diehn M, Cho RW and Clarke MF: Therapeutic
implications of the cancer stem cell hypothesis. Semin Radiat
Oncol. 19:78–86. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ghiaur G, Gerber J and Jones RJ: Concise
review: cancer stem cells and minimal residual disease. Stem Cells.
30:89–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
